Free Trial

ACADIA Pharmaceuticals (ACAD) SEC Filings & 10K Form

ACADIA Pharmaceuticals logo
$19.95 -0.34 (-1.68%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$19.32 -0.63 (-3.13%)
As of 02/21/2025 07:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent ACADIA Pharmaceuticals SEC Filings

DateFilerForm TypeView
02/14/2025
8:00 AM
ACADIA Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SCHEDULE 13G/A
02/07/2025
5:04 AM
ACADIA Pharmaceuticals (Subject)
BlackRock, Inc. (Filed by)
Form SCHEDULE 13G/A
12/11/2024
3:22 PM
ACADIA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2024
5:33 PM
ACADIA Pharmaceuticals (Issuer)
Garner Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
5:31 PM
ACADIA Pharmaceuticals (Issuer)
Garner Thomas (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/19/2024
7:40 PM
ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
7:41 PM
ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
7:43 PM
ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
5:48 AM
ACADIA Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G/A
10/15/2024
5:05 PM
ACADIA Pharmaceuticals (Issuer)
Ndu Adora (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2024
5:46 PM
ACADIA Pharmaceuticals (Issuer)
Adams Catherine Owen (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/25/2024
5:53 PM
ACADIA Pharmaceuticals (Issuer)
Adams Catherine Owen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2024
4:14 PM
ACADIA Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/23/2024
3:34 PM
ACADIA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2024
5:40 PM
ACADIA Pharmaceuticals (Issuer)
DAVIS STEPHEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
5:43 PM
ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
5:46 PM
ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:37 PM
ACADIA Pharmaceuticals (Filer)
Form S-8 POS
08/20/2024
3:39 PM
ACADIA Pharmaceuticals (Filer)
Form S-8 POS
08/20/2024
3:23 PM
ACADIA Pharmaceuticals (Filer)
Form S-8 POS
08/20/2024
3:25 PM
ACADIA Pharmaceuticals (Filer)
Form S-8 POS
08/20/2024
3:27 PM
ACADIA Pharmaceuticals (Filer)
Form S-8 POS
08/20/2024
3:29 PM
ACADIA Pharmaceuticals (Filer)
Form S-8 POS
08/20/2024
3:31 PM
ACADIA Pharmaceuticals (Filer)
Form S-8 POS
08/20/2024
3:33 PM
ACADIA Pharmaceuticals (Filer)
Form S-8 POS
08/13/2024
5:05 PM
ACADIA Pharmaceuticals (Issuer)
Thompson Elizabeth H.Z. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:13 PM
ACADIA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Brege Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
SOLAND DANIEL B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
HARRIGAN EDMUND (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Daly James M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
GAROFALO ELIZABETH A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Ndu Adora (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:23 PM
ACADIA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2024
3:21 PM
ACADIA Pharmaceuticals (Filer)
Form DEF 14A
04/15/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Thompson Elizabeth H.Z. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/09/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Watch This Robotics Demo Before March 17th (Ad)

Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."

04/09/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
DAVIS STEPHEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
6:58 PM
ACADIA Pharmaceuticals (Issuer)
DAVIS STEPHEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
7:00 PM
ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
7:02 PM
ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
6:57 PM
ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
5:07 PM
ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
5:10 PM
ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
5:13 PM
ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ACAD) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners